The cardiovascular safety of the obesity treatment naltrexone-bupropion remains uncertain because of the unanticipated early termination of a trial to determine its safety, according to a study...
from Obesity / Weight Loss / Fitness News From Medical News Today http://ift.tt/1R3RAyJ
mardi 8 mars 2016
weight loss fitnessCardiovascular safety of obesity treatment naltrexone-bupropion uncertain
Inscription à :
Publier les commentaires (Atom)
0 commentaires:
Enregistrer un commentaire